BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
17 results:

  • 1. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
    Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
    Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
    Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
    Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel insights into immunohistochemical analysis for diagnosing serous neoplasm of the pancreas: aquaporin 1, stereocilin, and transmembrane protein 255B.
    Watase C; Fuse M; Ino Y; Naito C; Hiraoka N
    Histopathology; 2021 Nov; 79(5):872-879. PubMed ID: 34288030
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National cancer Database.
    Barzi A; Yang D; Kim AW; Shah MA; Sadeghi S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33148789
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. fgfr3
    Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
    Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
    Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
    Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Therapeutics Targeting FGF Signaling Network in Human Diseases.
    Katoh M
    Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An fgfr3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in gastric cancer Patients.
    Piro G; Carbone C; Cataldo I; Di Nicolantonio F; Giacopuzzi S; Aprile G; Simionato F; Boschi F; Zanotto M; Mina MM; Santoro R; Merz V; Sbarbati A; de Manzoni G; Scarpa A; Tortora G; Melisi D
    Clin Cancer Res; 2016 Dec; 22(24):6164-6175. PubMed ID: 27267856
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells.
    Yang T; He W; Cui F; Xia J; Zhou R; Wu Z; Zhao Y; Shi M
    Oncotarget; 2016 Apr; 7(14):18085-94. PubMed ID: 26919111
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
    Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
    J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer.
    Wang L; Zhi X; Zhang Q; Wei S; Li Z; Zhou J; Jiang J; Zhu Y; Yang L; Xu H; Xu Z
    Tumour Biol; 2016 Feb; 37(2):2105-17. PubMed ID: 26346168
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of ALDH2 genotype, PPI treatment and L-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration.
    Maejima R; Iijima K; Kaihovaara P; Hatta W; Koike T; Imatani A; Shimosegawa T; Salaspuro M
    PLoS One; 2015; 10(4):e0120397. PubMed ID: 25831092
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FGF receptors: cancer biology and therapeutics.
    Katoh M; Nakagama H
    Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
    Yeh KH; Lu YS; Hsu CH; Lin JF; Hsu C; Kuo SH; Li SJ; Cheng AL
    Oncology; 2005; 69(1):88-95. PubMed ID: 16088236
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [FLEP therapy for advanced and recurrent gastric cancer].
    Mochizuki F; Fujii M; Kasakura Y; Kochi M; Wakabayashi K; Eguchi T; Tsuneda Y; Kanamori N; Kaiga T; Kobayashi M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1542-5. PubMed ID: 11707975
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer.
    Shin EY; Lee BH; Yang JH; Shin KS; Lee GK; Yun HY; Song YJ; Park SC; Kim EG
    J Cancer Res Clin Oncol; 2000 Sep; 126(9):519-28. PubMed ID: 11003564
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.